価格表

在庫・価格 : 2024年06月13日 14時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CD44, Rabbit-Poly
データシート
GTX102111 GNTジーンテックス
GeneTex International Corporation
25 μl ¥24,000
(未発注)
追加

在庫・価格 : 2024年06月13日 14時57分 現在

Anti-CD44, Rabbit-Poly

  • 商品コード:GTX102111
  • メーカー:GNT
  • 包装:25μl
  • 価格: ¥24,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Xie G et al. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines. Br. J. Cancer 2014 May;110(10):2514-23
Xie G et al
2014/01/01
Application: Western blot, Reactivity: Human PubMed
2 Liao CJ et al. Glucose-regulated protein 58 modulates β-catenin protein stability in a cervical adenocarcinoma cell line. BMC Cancer 2014;14:555
Liao CJ et al
2014/01/01
Application: Western blot, Reactivity: Human PubMed
3 Yokdang N et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene 2016 Jun;35(22):2932-47
Yokdang N et al
2016/01/01
PubMed
4 Ju SY et al. Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells. Cell Death Dis 2015 Jul;6:e1801
Ju SY et al
2015/01/01
PubMed
5 Lin CW et al. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release. Acta Biomater 2016 Apr;35:280-92
Lin CW et al
2016/01/01
PubMed
6 Huang D et al. Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina. Mol. Pharm. 2017 Feb;14(2):533-545
Huang D et al
2017/01/01
PubMed
7 Jiang X et al. Combination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis. Mol Med Rep 2017 Mar;15(3):1123-1134
Jiang X et al
2017/01/01
PubMed
8 Zhang Y et al. Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Oncotarget 2015 Apr;6(12):9999-10015
Zhang Y et al
2015/01/01
PubMed
9 Zhao B et al. Comprehensive proteome quantification reveals NgBR as a new regulator for epithelial-mesenchymal transition of breast tumor cells. J Proteomics 2015 Jan;112:38-52
Zhao B et al
2015/01/01
Application: Western blot, Reactivity: Human PubMed
10 Isayev O et al. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Oncotarget 2014 Jul;5(13):5177-89
Isayev O et al
2014/01/01
Application: IHC (Frozen sections), Reactivity: Human PubMed
11 Wang AM et al. Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis. Oncotarget 2014 Jul;5(13):5002-16
Wang AM et al
2014/01/01
Application: Western blot, Reactivity: Human PubMed
12 Ni YL et al. A potent indolylquinoline alleviates growth of human lung cancer cell tumorspheres. Apoptosis 2017 10;22(10):1235-1245
Ni YL et al
2017/01/01
Application: Western blot, Reactivity: Human PubMed
13 Tay LX et al. Differential protein expression between chondrogenic differentiated MSCs, undifferentiated MSCs and adult chondrocytes derived from Oryctolagus cuniculus in vitro. Int J Med Sci 2014;11(1):24-33
Tay LX et al
2014/01/01
Application: Immunocytochemistry/ Immunofluorescence, Reactivity: Rabbit PubMed
14 Lin PY et al. Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit. Am J Transl Res 2017;9(8):3827-3841
Lin PY et al
2017/01/01
Application: IHC (Formalin-fixed paraffin-embedded sections), Reactivity: Rabbit PubMed
15 Xiong J et al. A Metabolic Basis for Endothelial-to-Mesenchymal Transition. Mol. Cell 2018 Feb;69(4):689-698.e7
Xiong J et al
2018/01/01
Application: Western Blot (WB), Reactivity: Mouse PubMed
16 Chang CC et al. The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis. Sci Rep 2018 Jun;8(1):9786
Chang CC et al
2018/01/01
Application: Western Blot (WB), Reactivity: Human PubMed
17 Sun SJ et al. Integrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth. Oncotarget 2016 08;7(34):55572-55584
Sun SJ et al
2016/01/01
Application: Immunocytochemistry/ Immunofluorescence (ICC/IF), Reactivity: Human PubMed
18 Chang YT et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep 2017 03;7:42795
Chang YT et al
2017/01/01
PubMed
19 Nan JN et al. β-Catenin expression is associated with cell invasiveness in pancreatic cancer. Korean J. Intern. Med. 2019 May;34(3):618-625
Nan JN et al
2019/01/01
Application: Western Blot, Reactivity: Human PubMed
20 Sikorski K et al. A high-throughput pipeline for validation of antibodies. Nat. Methods 2018 11;15(11):909-912
Sikorski K et al
2018/01/01
Application: Immunoprecipitation, Reactivity: Human PubMed
21 Lin YH et al. Thyroid hormone negatively regulates tumorigenesis through suppression of BC200. Endocr. Relat. Cancer 2018 12;25(12):967-979
Lin YH et al
2018/01/01
Application: Western Blot, Reactivity: Human PubMed
22 Li G et al. Generation and Characterization of Induced Pluripotent Stem Cells and Retinal Organoids From a Leber&quot;s Congenital Amaurosis Patient With Novel <i>RPE65</i> Mutations. Front Mol Neurosci 2019;12:212
Li G et al
2019/01/01
PubMed
23 Lai HT et al. MicroRNA-203 diminishes the stemness of human colon cancer cells by suppressing GATA6 expression. J. Cell. Physiol. 2020 Mar;235(3):2866-2880
Lai HT et al
2020/01/01
PubMed
24 LaRocca TJ et al. TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol. Dis. 2019 12;132:104514
LaRocca TJ et al
2019/01/01
PubMed
25 Chung SY et al. Elucidation of the mechanism underlying CD44v6-induced transformation of IEC-6 normal intestinal epithelial cells. J. Cell. Physiol. 2020 01;235(1):194-209
Chung SY et al
2020/01/01
PubMed
26 Lin SC et al. Role of syndecan-1 and exogenous heparin in hepatoma sphere formation. Biochem. Cell Biol. 2019 May;
Lin SC et al
2019/01/01
PubMed
27 Su YH et al. A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids. Oncotarget 2018 Apr;9(29):20490-20507
Su YH et al
2018/01/01
PubMed
28 Offeddu GS et al. The cancer glycocalyx mediates intravascular adhesion and extravasation during metastatic dissemination. Commun Biol 2021 Feb;4(1):255
Offeddu GS et al
2021/01/01
PubMed
29 Yeh BW et al. The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy. Toxicol Appl Pharmacol 2020 09;402:115129
Yeh BW et al
2020/01/01
PubMed
30 Teiichiro Aoyagi et al., Teiichiro Aoyagi, Scientific Research, 2020

PubMed
31 Aoyagi T et al., Aoyagi T, JCT, 2018

PubMed
32 Jin L et al., Jin L, Animal Cells and Systems, 2014

PubMed
33 Ma L et al., Ma L, Biochem Biophys Res Commun, 2014

PubMed
34 Howley BV et al. The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression. Oncogene 2022 Jan;
Howley BV et al
2022/01/01
PubMed
35 Young MJ et al. Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression. J Biomed Sci 2022 Jan;29(1):3
Young MJ et al
2022/01/01
PubMed
36 Chen YA et al. Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands. Sci Rep 2021 11;11(1):22430
Chen YA et al
2021/01/01
PubMed
37 Mir C et al. SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation. Cancers (Basel) 2021 Oct;13(19)
Mir C et al
2021/01/01
PubMed
38 Wang T et al. SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-&#x3B2;-independent manner. Mol Oncol 2024 Jan;18(1):44-61
Wang T et al
2024/01/01
PubMed
39 Şen Ö et al. Microglia Polarization and Antiglioma Effects Fostered by Dual Cell Membrane-Coated Doxorubicin-Loaded Hexagonal Boron Nitride Nanoflakes. ACS Appl Mater Interfaces 2023 Dec;15(50):58260-58273
Şen Ö et al
2023/01/01
PubMed
40 Chu PY et al. IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis. Cell Biosci 2022 Aug;12(1):124
Chu PY et al
2022/01/01
PubMed
41 Vadhan A et al. CD44 Promotes Breast Cancer Metastasis through AKT-Mediated Downregulation of Nuclear FOXA2. Biomedicines 2022 Oct;10(10)
Vadhan A et al
2022/01/01
PubMed
42 Wuputra K et al. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells. Int J Mol Sci 2022 Jul;23(14)
Wuputra K et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Xie G et al. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines. Br. J. Cancer 2014 May;110(10):2514-23
    Xie G et al
    2014/01/01
  • 備考:
    Application: Western blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Liao CJ et al. Glucose-regulated protein 58 modulates &#x3B2;-catenin protein stability in a cervical adenocarcinoma cell line. BMC Cancer 2014;14:555
    Liao CJ et al
    2014/01/01
  • 備考:
    Application: Western blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Yokdang N et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene 2016 Jun;35(22):2932-47
    Yokdang N et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Ju SY et al. Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells. Cell Death Dis 2015 Jul;6:e1801
    Ju SY et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Lin CW et al. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release. Acta Biomater 2016 Apr;35:280-92
    Lin CW et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Huang D et al. Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina. Mol. Pharm. 2017 Feb;14(2):533-545
    Huang D et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Jiang X et al. Combination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis. Mol Med Rep 2017 Mar;15(3):1123-1134
    Jiang X et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Zhang Y et al. Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Oncotarget 2015 Apr;6(12):9999-10015
    Zhang Y et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Zhao B et al. Comprehensive proteome quantification reveals NgBR as a new regulator for epithelial-mesenchymal transition of breast tumor cells. J Proteomics 2015 Jan;112:38-52
    Zhao B et al
    2015/01/01
  • 備考:
    Application: Western blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Isayev O et al. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Oncotarget 2014 Jul;5(13):5177-89
    Isayev O et al
    2014/01/01
  • 備考:
    Application: IHC (Frozen sections), Reactivity: Human
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Wang AM et al. Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis. Oncotarget 2014 Jul;5(13):5002-16
    Wang AM et al
    2014/01/01
  • 備考:
    Application: Western blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Ni YL et al. A potent indolylquinoline alleviates growth of human lung cancer cell tumorspheres. Apoptosis 2017 10;22(10):1235-1245
    Ni YL et al
    2017/01/01
  • 備考:
    Application: Western blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Tay LX et al. Differential protein expression between chondrogenic differentiated MSCs, undifferentiated MSCs and adult chondrocytes derived from Oryctolagus cuniculus in vitro. Int J Med Sci 2014;11(1):24-33
    Tay LX et al
    2014/01/01
  • 備考:
    Application: Immunocytochemistry/ Immunofluorescence, Reactivity: Rabbit
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Lin PY et al. Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit. Am J Transl Res 2017;9(8):3827-3841
    Lin PY et al
    2017/01/01
  • 備考:
    Application: IHC (Formalin-fixed paraffin-embedded sections), Reactivity: Rabbit
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Xiong J et al. A Metabolic Basis for Endothelial-to-Mesenchymal Transition. Mol. Cell 2018 Feb;69(4):689-698.e7
    Xiong J et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB), Reactivity: Mouse
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Chang CC et al. The role of sentrin-specific protease 2 substrate recognition in TGF-&#x3B2;-induced tumorigenesis. Sci Rep 2018 Jun;8(1):9786
    Chang CC et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB), Reactivity: Human
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Sun SJ et al. Integrin &#x3B2;3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth. Oncotarget 2016 08;7(34):55572-55584
    Sun SJ et al
    2016/01/01
  • 備考:
    Application: Immunocytochemistry/ Immunofluorescence (ICC/IF), Reactivity: Human
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Chang YT et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep 2017 03;7:42795
    Chang YT et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Nan JN et al. &#x3B2;-Catenin expression is associated with cell invasiveness in pancreatic cancer. Korean J. Intern. Med. 2019 May;34(3):618-625
    Nan JN et al
    2019/01/01
  • 備考:
    Application: Western Blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Sikorski K et al. A high-throughput pipeline for validation of antibodies. Nat. Methods 2018 11;15(11):909-912
    Sikorski K et al
    2018/01/01
  • 備考:
    Application: Immunoprecipitation, Reactivity: Human
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Lin YH et al. Thyroid hormone negatively regulates tumorigenesis through suppression of BC200. Endocr. Relat. Cancer 2018 12;25(12):967-979
    Lin YH et al
    2018/01/01
  • 備考:
    Application: Western Blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Li G et al. Generation and Characterization of Induced Pluripotent Stem Cells and Retinal Organoids From a Leber&quot;s Congenital Amaurosis Patient With Novel <i>RPE65</i> Mutations. Front Mol Neurosci 2019;12:212
    Li G et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Lai HT et al. MicroRNA-203 diminishes the stemness of human colon cancer cells by suppressing GATA6 expression. J. Cell. Physiol. 2020 Mar;235(3):2866-2880
    Lai HT et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    LaRocca TJ et al. TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol. Dis. 2019 12;132:104514
    LaRocca TJ et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Chung SY et al. Elucidation of the mechanism underlying CD44v6-induced transformation of IEC-6 normal intestinal epithelial cells. J. Cell. Physiol. 2020 01;235(1):194-209
    Chung SY et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Lin SC et al. Role of syndecan-1 and exogenous heparin in hepatoma sphere formation. Biochem. Cell Biol. 2019 May;
    Lin SC et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Su YH et al. A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids. Oncotarget 2018 Apr;9(29):20490-20507
    Su YH et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Offeddu GS et al. The cancer glycocalyx mediates intravascular adhesion and extravasation during metastatic dissemination. Commun Biol 2021 Feb;4(1):255
    Offeddu GS et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Yeh BW et al. The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy. Toxicol Appl Pharmacol 2020 09;402:115129
    Yeh BW et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Teiichiro Aoyagi et al., Teiichiro Aoyagi, Scientific Research, 2020

  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Aoyagi T et al., Aoyagi T, JCT, 2018

  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Jin L et al., Jin L, Animal Cells and Systems, 2014

  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Ma L et al., Ma L, Biochem Biophys Res Commun, 2014

  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Howley BV et al. The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression. Oncogene 2022 Jan;
    Howley BV et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Young MJ et al. Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression. J Biomed Sci 2022 Jan;29(1):3
    Young MJ et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Chen YA et al. Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands. Sci Rep 2021 11;11(1):22430
    Chen YA et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Mir C et al. SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation. Cancers (Basel) 2021 Oct;13(19)
    Mir C et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Wang T et al. SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-&#x3B2;-independent manner. Mol Oncol 2024 Jan;18(1):44-61
    Wang T et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Şen Ö et al. Microglia Polarization and Antiglioma Effects Fostered by Dual Cell Membrane-Coated Doxorubicin-Loaded Hexagonal Boron Nitride Nanoflakes. ACS Appl Mater Interfaces 2023 Dec;15(50):58260-58273
    Şen Ö et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Chu PY et al. IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis. Cell Biosci 2022 Aug;12(1):124
    Chu PY et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Vadhan A et al. CD44 Promotes Breast Cancer Metastasis through AKT-Mediated Downregulation of Nuclear FOXA2. Biomedicines 2022 Oct;10(10)
    Vadhan A et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Wuputra K et al. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells. Int J Mol Sci 2022 Jul;23(14)
    Wuputra K et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed